A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Inclusion Criteria: * Healthy adult aged 19 to 50 (inclusive) years * Subjects weighing between 50 kg and 90 kg with BMI between 18 and 27 kg/m2 (inclusive) Exclusion Criteria: * clinical significant liver, kidney, nervous system, respiratory, endocrine, hematology and oncology, cardiovascular, urinary, and mental diseases or past history